Global AI In Pharma Market
Information Technology

Global AI In Pharma Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends

The Global AI In Pharma Market Report by The Business Research Company covers AI in pharma market drivers and restraints, AI in pharma market size, major players, and the impact of COVID-19 on the AI in pharma market.

 The artificial intelligence (AI) in pharma market consists of sales of AI software products in the pharma and related services that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be useful in handling data and presenting results that encourage better decision-making and save human efforts, cost, and time.

The global AI in pharma market reached a value of nearly $699.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 31.8 % since 2015. The market is expected to grow from $699.3 million in 2020 to $2,895.5 million in 2025 at a rate of 32.9%. The AI in pharma market is then expected to grow at a CAGR of 25.9% from 2025 and reach $9,142.7 million in 2030.

To bring a new drug to the market takes on an average 10-15 years approximately and half of this time is consumed during the clinical trial phases of the drug development cycle. Hence, using AI models and analytics tools can accelerate the clinical trial phases, perception of diseases, identify suitable cases and key investigators to inform site selection, and support novel clinical study designs.

Request A Sample For The Global AI In Pharma Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5352&type=smp

Some artificial intelligence in pharma market trends include use of AI for clinical trials. AI can be used to make sense of the vast amount of patient, research, and diagnostic data which is gathered every day. Moreover, companies in the AI in pharma market are developing drugs for rare diseases through advancements in AI. The technology is being used to develop personalized drug treatments based on an individual’s genes, environment, and lifestyle.

Global AI in pharmaceuticals market segments include:

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

2) By Drug Type: Small Molecule, Large Molecules

3) By Application: Clinical Trial Research, Drug Discovery, Research and Development, Others

4) By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

 

Read More On The AI In Pharma Opportunities and Strategies: Forecast To 2030:

https://www.thebusinessresearchcompany.com/report/AI-in-pharma-market

 

The AI In Pharma Opportunities and Strategies: Forecast To 2030 is one of a series of new reports from The Business Research Company that provides AI in pharma market overviews, analyzes and forecasts market size, share, AI in pharma market players, AI in pharma market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.

The AI in pharma identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More:

Read AI In Pharma Opportunities and Strategies: Forecast To 2030 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Market Players Covered: IBM Watson Health, Alphabet Inc., Concreto HealthAI, Nvidia Corporation, PathAI

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The AI In Pharma Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.

Opportunities For Companies In The AI In Pharma Sector: The report reveals where the global industry will put on most $ sales up to 2023.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at www.thebusinessresearchcompany.com

Here is a list of reports from The Business Research Company similar to the AI In Pharma Global Market Report 2021:

Artificial Intelligence Global Market Report 2021

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2021

Artificial Intelligence Services Global Market Report 2021

Reach us at:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow us on LinkedIn: https://bit.ly/3b7850r

Follow us on Facebook: https://bit.ly/3lyGAlo

Follow us on Twitter: https://bit.ly/3b1rmjS

Leave a Reply

Your email address will not be published. Required fields are marked *